
Bharat Biotech has today announced to increase the capacity to produce 70 million doses of COVAXIN in a year. This goal will be achieved in a phased manner in Hyderabad, and Bengaluru. The company says that capacity expansion in vaccine manufacturing is a long and tedious process. It requires several crores of rupees and many years of investment.
The company said, "Bharat Biotech can expand its capacity to manufacture COVAXIN in a short time." The main reason for this is the availability of specially designed BSL-3 facilities. ”The company said that specialist partners are being sought for vaccine manufacturing in other countries.
Bharat Biotech has partnered with Indian immunologists (IIL) to increase capacity. The process of technology transfer is well underway and IIL has the capability and expertise to manufacture inactivated viral vaccines on a commercial scale and under biosafety control. Bharat Biotech uses a proprietary subsidiary Algel-IMDG, which has now proven to be a safe and effective adjuvant, particularly to stimulate memory T cell responses.
COVAXIN has been approved for emergency use in many countries of the world. With this, negotiations are going on in more than 60 countries. Emergency use has been approved in several other countries including Mexico, the Philippines, Iran, Paraguay, Guatemala, Nicaragua, Guyana, Venezuela, Botswana, Zimbabwe. Talk continues in the United States and many European countries.
On the orders of the Supreme Court, District Magistrate S. It started at 9:30 on Saturday morning
Political upheaval continues in Rajasthan regarding cabinet expansion and political appointments.
Earthquake tremors have been felt in Jammu and Kashmir. According to the earthquake mobile app, t
After the declaration of a ceasefire between India and Pakistan, the situation in both countries
RCB vs CSK: The 24th match of IPL 2023 was played between Royal Challengers Bangalore and Chennai
The third match of the 5-match T20 series being played between India and South Africa will be pla
Covid JN.1 cases in India. The new variant of Covid JN.1 has knocked. In the last few days, the n
Union Minister of State (MoS) Nityanand Rai said in the Lok Sabha on Tuesday that the problem of
During the winter session, the government withdrew all three agriculture laws. The Agricultural L
The way the crisis in Uddhav Thackeray's chair has deepened in Maharashtra, the failure of police